TFLL Pharma
Life Sciences Incubator Belgium B. Abis B. Abis /
3590 Diepenbeek
BE
TFLL Pharma
Foundation date
21/09/2017
Sector
#PharmaSubsector
- #Pharma - Anti-infectives
- #Pharma - Antibodies
- #Pharma - Biosimilars
- #Pharma - Cell therapy
- #Pharma - Drug delivery
- #Pharma - Gene therapy
- #Pharma - Generics
- #Pharma - Molecular diagnostics
- #Pharma - Nucleic acid drugs
- #Pharma - Peptides
- #Pharma - Proteins
- #Pharma - Small molecule therapeutics
- #Pharma - Stem cells
- #Pharma - Vaccines
Therapeutic areas
TFLL Pharma is a Contract Development Company which develops conventional finished dosage forms and special biotechnological products such as peptides for Pharmaceutical Companies. Expertise Small Molecules Solid dosage forms (Oral) Semi solid dosage and liquid forms (Topical) Parenteral dosage forms (Lyophilized, Liquid and PFS) Liquid dosage forms (Oral suspension and Solution)
Upcoming events
All events-
2211 '21
Translational Immunology
Event by: VIB -
2710 '21
New Horizons in Alzheimer's Disease
Event by: VIB -
1611 '21
DxPx Conference 2021
Event by: DxPx Conference
Latest news
More news-
reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase
Thursday October 21st 2021
Read more
-
Mithra announces Estelle® launch in Belgium
Thursday October 21st 2021
Read more
-
Biotalys awarded multi-year grant to develop new biological solutions for cowpea and other legumes
Wednesday October 20th 2021
Read more